Shionogi Invests $2.1 Billion to Raise ViiV Healthcare Stake
Japanese drugmaker company Shionogi & Co. will invest $2.1 billion to raise its stake in ViiV Healthcare to 21.7%, reinforcing its focus on HIV and other major infectious diseases.
By Kanoko Matsuyama · Bloomberg Markets
Japanese drugmaker company Shionogi & Co. will invest $2.1 billion to raise its stake in ViiV Healthcare to 21.7%, reinforcing its focus on HIV and other major infectious diseases.